1. Lobaric acid and pseudodepsidones inhibit NF-κB signaling pathway by activation of PPAR-γ.
- Author
-
Carpentier C, Barbeau X, Azelmat J, Vaillancourt K, Grenier D, Lagüe P, and Voyer N
- Subjects
- Anti-Inflammatory Agents, Non-Steroidal chemistry, Anti-Inflammatory Agents, Non-Steroidal isolation & purification, Cell Survival drug effects, Depsides chemistry, Depsides isolation & purification, Dose-Response Relationship, Drug, Humans, Lactones chemistry, Lactones isolation & purification, Lipopolysaccharides antagonists & inhibitors, Lipopolysaccharides pharmacology, Macrophages drug effects, Molecular Docking Simulation, Molecular Structure, NF-kappa B metabolism, PPAR gamma metabolism, Salicylates chemistry, Salicylates isolation & purification, Signal Transduction drug effects, Structure-Activity Relationship, U937 Cells, Anti-Inflammatory Agents, Non-Steroidal pharmacology, Depsides pharmacology, Lactones pharmacology, Lichens chemistry, NF-kappa B antagonists & inhibitors, PPAR gamma agonists, Salicylates pharmacology
- Abstract
Herein we report the anti-inflammatory activity of lobaric acid and pseudodepsidones isolated from the nordic lichen Stereocaulon paschale. Lobaric acid (1) and three compounds (2, 7 and 9) were found to inhibit the NF-κB activation and the secretion of pro-inflammatory cytokines (IL-1β and TNF-α) in LPS-stimulated macrophages. Inhibition and docking simulation experiments provided evidence that lobaric acid and pseudodepsidones bind to PPAR-γ between helix H3 and the beta sheet, similarly to partial PPAR-γ agonists. These findings suggest that lobaric acid and pseudodepsidones reduce the expression of pro-inflammatory cytokines by blocking the NF-κB pathway via the activation of PPAR-γ., (Copyright © 2018 Elsevier Ltd. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF